The objective of the study was to isolate bioactive acetogenin compound and to investigate antimicrobial, antioxidant as well as cytotoxic activities of the isolate, fractions and extracts of Polyalthia debilis. The P. debilis (roots) extracts and isolated compound were tested for their antimicrobial (agar dilution method) against twentyseven strains of microorganisms (gram positive and gram negative bacteria, and diploid fungus), antioxidant (DPPH assay) and cytotoxic activities. The plant extracts were isolated by column chromatography and structure of compound was confirmed by spectral data. The plant extracts and isolated fractions exhibited antioxidant and cytotoxic activities. The isolated acetogenin 1 (debilisone E) displayed antimicrobial activity against Morexella catarrhalis with the MIC of 64 g/mL, Corynebacterium diphtheriae NCTC 10356 and Streptococcus pyogenes with partial inhibition (50-75%) at 128 g/mL. The compound 1 exerted cytotoxic activity against 5 cancer cells (HepG2, A549, HCC-S102,HL-60 and P388) with IC50 values 18.4 -40.3g/mL. The results demonstrate novel bioactivities of P. debilis as antimicrobials and anticancer agents.
INTRODUCTION
Polyalthia debilis (Annonaceae), a Thai medicinal plant, has been used as folk remedy for treatment of abdominal pain and tuberculosis and as a febrigue and a galactogogue . A variety of compounds were found in the P. debilis i.e., diterpenes, triterpenes, polyacetylene and alkaloids (Panthama et al., 2010; Kanokmedhakul et al., 2003) . Previously, bioactive azafluorenone alkaloids from roots of the plant species were reported . To continue our study on the Thai medicinal plant, herein, antimicrobial and cytotoxic compounds as well as antioxidant activity of the P. debilis have been investigated.
.
MATERIALS AND METHODS

General
1 H -and 13 C-NMR spectra were recorded on Bruker AVANCE 300 and 600 NMR spectrometers (operating at 300 and 600 MHz for 1 H, and 75 and 125 MHz for 13 C, respectively). Infrared spectra (IR) were obtained on a Perkin Elmer System 2000 FTIR. Ultraviolet (UV) spectra were recorded on a Shimadzu UV 240 IPC. Mass spectra were recorded on a Finnigan INCOS 50 and Bruker Daltonics (micro TOF). Column chromatography was carried out using silica gel 60 (0.063-0.200 mm). Analytical thin layer chromatography (TLC) was performed on silica gel 60 PF 254 aluminum sheets (cat. No. 7747 E., Merck) . Melting points were determined on an Electrothermal melting point apparatus (Electrothermal 9100) and are uncorrected. Solvents were distilled prior to use. Reagents for cell culture and assays were of analytical grade: RPMI-1640 (Rosewell Park Memorial Institute medium, Gibco and Hyclone laboratories, USA), Ham's/F12 (Nutrient . mixture F-12), DMEM (Dulbecco's Modified Eagle's Medium) and FBS (fetal bovine serum, Hyclone laboratories, USA) HEPES (N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid), L glutamine, penicillin-streptomycin, sodium pyruvate, glucose, crystal violet,
MTT (3(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide), XTT (2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide salt) from SigmaAldrich, USA, and gentamicin sulfate (Government Pharmaceutical Organization, Thailand).
Plant materials
P. debilis roots were collected from Ubonratchatanee Province, Thailand. It has been identified (BKF 135063) by The Forest Herbarium, Royal Forestry Department, Bangkok. The plant extracts; hexane (PH), chloroform (PC), ethyl acetate (PE) and methanol (PM) were prepared as previously described .
Isolation
Chloroform extract (PC, 100 g) was isolated by a silica gel column ) to give 9 fractions (C1-C9). Fraction C6 (17 g) was subjected to column chromatography to provide seven fractions (C6.1-C6.7) in which C6.6 (15.1g) was rechromatographed on the silica gel (55g) column. Elution with increasing polarity of solvent (hexane : acetone) gave 11 fractions (C6.6.1-C6.6.11) of yellow oil and dark brown gum. The fraction C6.6.7 (350 mg) as an orange oil from hexane : acetone (92:8) was further isolated on the silica gel (20 g) column, eluted with hexane:acetone (9:1) afforded compound 1 (237 mg) as white solid, mp 63-65 °C. Rf = 0.73 (hexane:acetone, 8:2 ) . UV(EtOH) λmax (log ε) 214 (4.33), 253 (4.14), 276 (4.30), 283 (4.21) nm. IR (UATR): υ max 3469, 3078, 2919, 2850, 2225, 1769, 1641, 1469, 1169, 1046, 947 
Bioactivities
Antimicrobial Assay
Antimicrobial activity of the tested compound was assayed using the agar dilution method (Srisung et al., 2013 ).
Briefly, the tested compound dissolved in DMSO was mixed with 1 mL Müller Hinton (MH) broth while the MH broth was used as the negative control. The two-fold dilution solution was transferred to the MH agar solution to yield the final concentrations of 32-256 µg/mL. The DMSO was tested in parallel with the compound and showed no effect on the tested organisms. Twenty -seven strains of microorganisms, cultured in the MH broth at 37 °C for 24 h, were diluted with 0.9 % normal saline solution to adjust the cell density of 3 × 10 9 cell/mL. The organisms were inoculated onto each plate and further incubated at 37 °C for 18-48 h. Efficacy of the compound to inhibit bacterial cell growth was analyzed. 
Antimalarial assay
Antimalarial activity of the tested compound was performed against chloroquine resistant Plasmodium falciparum (T9.94) using the literature method (Targer and Jensen, 1976; Lambros and Vanderberg, 1979) . Human erythrocytes (type O) infected with chloroquine resistant P. falciparum (T9.94) were maintained in continuous culture as described previously (Targer and Jensen, 1976) . RPMI 1640 culture medium supplemented with HEPES (25 mM), gentamicin sulfate (40 mg/mL) and human serum (10 mL) was used in continuous culture. Before performing the experiment, P. falciparum culture was synchronized (Lambros and Vanderberg, 1979) by using sorbitol induced hemolysis to obtain only ring stage-infected red blood cells and then incubated for 48 h prior to the drug testing to avoid effect of sorbitol.
The experiments were carried out using synchronized suspension (0.5% to 1%) of infected red blood cell during ring stage. Parasites were suspended in culture medium supplemented with human serum (15%) to obtain 10% cell suspension. The parasite suspension was added into 96-well microculture plate; 50 µL in each well and then add 50 µL of various tested drug concentrations. The parasite suspensions were incubated for 48 h in the atmosphere of 5% CO2 at 37 °C. Percents parasitemia of the control and tested compound were examined by microscopic technique using methanol-fixed Giemsa stained of thin smear blood preparation. Efficacy of the compound was determined by compound concentration that reduced parasite growth by 50% (IC 50 ). 100 .
Abs Abs
Antioxidant assay
Antioxidant activity of compound was tested using 2,2-diphenyl-1-picrylhydrazyl (DPPH) assay. The DPPH (a stable purple color radical) reacts with an antioxidant to form a lightyellow colored of diphenylpicrylhydrazine, the reduced product that can be spectrophotometrically detected. The assay (Prachayasittikul et al., 2012) was performed by adding 1 mL solution of DPPH in methanol (0.1 mM) to a sample solution (0.45 mL, 1 mg/mL dissolved in DMSO). The reaction mixture was incubated for 30 min in a dark room and the absorbance at 517 nm was measured using UV-visible spectrophotometer (UV-1610, Shimadzu). Percentage of radical scavenging activity (RSA) was deduced from the following equation:
where Abs. control is the absorbance of the control reaction and Abs. sample is the absorbance of the tested compound.
Cytotoxic assay
Cytotoxic assays were performed using the method described previously . Cell lines suspended in RPMI-1640 containing 10% FBS were seeded at 1x 10 4 cells (100 µL) per well in 96-well plate, and incubated in humidified atmosphere, 95% air, 5% CO2 at 37 °C. After 24 h, additional medium (100 µL) containing the tested compound and vehicle was added to a final concentration of 50 µg/mL, 0.2% DMSO, and further incubated for 3 days.
Cells were subsequently fixed with 95% EtOH, stained with crystal violet solution, then lysed with a solution of 0.1 N HCl in MeOH, and an absorbance was measured at 550 nm. Whreas HuCCA-1, A549 and HepG2 cells were stained by MTT and for MOLT-3 cell was stained by XTT. IC 50 values were determined as the drug and sample concentration at 50% inhibition of the cell growth. The tested cancer cell lines were human cholangio carcinoma cell line (HuCCA-1), human epidermoid carcinoma of the mouth (KB), human promyelocytic leukemia cell line (HL-60), murine leukemia cell line (P388), cervical adenocarcinoma cell line (HeLa), hormone-independent breast cancer cell line (MDA-MB231), hormone-dependent breast cancer cell line (T47D), multidrug-resistance small cell lung cancer cell line (H69AR), human hepatocellular carcinoma cell line (HepG2), human lung carcinoma cell line (A549), and hepatocellular carcinoma cell line (HCC-S102). Cells were grown in Ham's/F12 medium containing L-glutamine (2 mM) supplemented with 100 U/mL penicillin-streptomycin and FBS (10%), except for, HepG2 cell was grown in DMEM medium.
RESULTS
Isolation
The fraction C6 of chloroform extract (PC) was extensively isolated by the silica gel column to give acetogenin compound 1 (Fig 1) . Its structure was determined by comparison of 1 H and 13 C NMR,MS, IR and UV spectra with the reported debilisone E (Panthama et al., 2010). 
Biological activities
Antioxidant activity
The plant extracts and isolated fractions were tested for their radical scavenging activity using DPPH assay. Results (Table  1) showed that the extracts (PC,PE and PM) displayed antioxidant activity with IC 50 values of 457.0, 154.9 and 128.8 µg/mL, respectively. The isolated fractions (C9, E4 and E5) exhibited the activity with IC 50 range of 100.0 -354.8 µg/mL. The fractions (C2,C4,C6,C7 and E3.6) and the extract (PH) were shown to be inactive antioxidants. 
Cytotoxic activity
The extracts (PH,PC,PE and PM) and isolated fractions (C2-C9, E4-E5 and E3.6) were tested at 10 and 50 µg/mL for their cytotoxic activities against 8 cancer cells. Results (Table 2) revealed that PH and PC extracts at 50 µg/mL displayed 80-100 % cytotoxicity toward 7 cell lines (HuCCA-1, KB, HL-60, P388, HeLa, MDA-MB231 and T47D). Most fractions of chloroform extract (C3-C9) exhibited cytotoxic activity (80-100 %) toward 5 cell lines (KB, P388, HeLa, MDA-MB231 and T47D). All fractions (C3-C9) showed 100 % inhibition on MDA-MB231 cell whereas 100 % inhibition of KB cell were observed for fractions C3-C7. Fraction E3.6 of ethyl acetate extract (PE) exerted 100 % inhibition toward the tested cells, except for HL60 and P388 were inhibited by 84 % and 92 % respectively. Fractions C2, E4 and E5 were shown to be inactive cytotoxic compounds (< 50 % inhibition). At 10 mg/mL (Table 3) , the extracts and fractions were found to be inacive, except for fractions C3-C6 were active against MDA-MB231 (68-98 % inhibition) and fractions C6-C9 showed inhibitory effect (73-90 % inhibition) toward P388 cell.
Bioactivity of compound 1
The isolated acetogenin compound 1 was tested for its bioactivities including antimicrobial activity against 27 strains of microorganisms (gram positive and gram negative bacteria and diploid fungus) using the agar dilution method, antimalarial activity against chloroquine resistant P. falciparum (T9.94), and cytotoxic activity toward 5 cancer cells (HepG2, A549, HCC-S102, HL 60 and P388). It was found that (Table 4 ) compound 1 displayed antibacterial activity against gram negative bacteria , M. catarrhalis with MIC value of 64 µg/mL; and gram positive bacteria at 128 µg/mL, C. diphtheriae NCTC 10356 (50% inhibition) and S. pyogenes (75% inhibition) . However, no antimalarial activity was observed for compound 1. Cytotoxic activity of compound 1 was found in 5 cancer cells including Hep G2, A549,HCC-S102,HL 60 and P388 (Table 5) with IC 50 range of 18.4 -40.3 µg/mL. Cytotoxocity of etoposide was determined as IC50 (µg/mL). HeLa  MDA-MB231  T47D  H69AR  PH  PC  PE  PM  C2  C3  C4  C5  C6  C7  C8  C9  E3.6  E4  E5  Compound 1  Etoposide   b   30  31  8  5  0  5  38  35  49  16  14  12  36  3  1  10  3   13  18  8  7  2  39  26  50  17  11  10  67  1  7  8  8 55  55  31  6  31  95  98  92  68  41  40  35  56  29  23  39  0.20   35  35  22  11  21  57  58  83  67  40  28  70  48  24 
DISCUSSION
Previously, two bioactive azafluorenone alkaloids, onychine and 7-methoxyonychine together with a mixture of β-sitosterol and stigmasterol were isolated from roots chloroform extract (PC) of the P.debilis . This study, the fraction C6 of PC extract was isolated by silica gel column to afford a linear acetylenic and olefinic C25 acetogenin (1) known as debilisone E (Panthama et al., 2010) . Its structure was confirmed by spectral data (H 1 and C 13 NMR, MS, IR and UV). The acetogenin 1 was reported to be found in methanol extract of roots P. debilis (Panthama et al., 2010) . Antioxidant potency of the palnt extracts and isolated fractions was investigated (DPPH assay).
The results showed that most of the extracts, except for PH, and some isolated fractions displayed relatively weak radical scarvenging activity. However, antioxidant activity of the P. debilis has never been reported elsewhere. The antioxidant activity of the plant extracts and isolated fractions could possibly be derived from the origin of plant triterpenoids i.e., stigmasterol . Stigmasterol is a phytosterol showing antioxidant effect, determined by the thiocyanate mehod (Hung and Yen, 2001) , and lipid peroxdation (Ramadan et al., 2007) .
In addition, the plant extracts and isolated fractions were assayed for their cytotoxic activity against 8 cancer cells (HuCCA-1, KB, HL-60, P388, HeLa, MDA-MB231, T47D and H69AR) at two concentrations, 10 and 50 µg/mL. Obviously, high cytotoxicity (80-100%) mostly up to 100 % was noted for 50 µg/mL of extracts (PH and PC) toward the tested cells, except for H69AR cell; and of fractions (C3-C9 and E3.6) toward KB, HeLa, MDA-MB231 and T47D cells. Particularly, such extracts and fractions displayed 100% cytotoxicity against MDA-MB231 cell, while inhibition (100%) of KB cell was found in the extracts (PH and PC) and fractions (C3-C7 and E3.6).
At low concentration (10µg/mL ), MDA-MB231 cell was inhibited (55-98%) by the extracts (PH and PC) and some fractions (C3-C6 and E 3.6). Similarly, P388 cell was inhibited (65-90%) by the extracts (PH and PC) and fractions (C4, C6-C9 and E3.6). It should be noted that no inhibition at 10 µg/mL was found in HL-60 cells. Improved cytotoxicity (from 0 to 84%) on HL-60 was observed at 50 µg/mL. Mostly, compound 1 displayed 100 % cytotoxicity toward the tested cells. Its IC 50 values toward Hep G2, A549, HCC-S102, HL 60 and P388 were 25.0, 27.5, 30.5, 40.3 and 18 .4 µg/mL, respectively. In addition, the acetogenin compound 1 exerted antibacterial activity against M. catarrhalis, C. diphtheriae NCTC 10356 and S. pyogenes. However, it was shown to be inactive antimalarial agent as indicated by IC 50 > 10 -5 M.
Previously, compound 1 was reported to display moderate antimycobacterial activity (Panthama et al., 2010) . So far, antimicrobial and cytotoxic activities of compound 1 have never been reported. Diverse biological activities of acetogenins were documented such as cytotoxic, antitumoural, antiparasitic and antimalarial activities (Bermejo et al., 2005) . Studies on mechanism of action showed that acetogenins are the most potent inhibitors of mitochondrial respiratory chain complex I (Bermejo et al., 2005) . Particularly, Annonaceous acetogenins kill cancer cells by inhibition of mitochondrial complex I (NADH-ubiquinone oxidoreductase) (Choo et al.,2014; Zafra-Polo et al., 1998) .
In conclusion, the P. debilis extracts and isolated fractions exhibited antioxidant activity and cytotoxicity toward a panel of cancer cells. The isolated acetogenin 1 (debilisone E) displayed novel bioactivities as antibacterial and anticancer agents. The finding demonstrates compound 1 as potential lead to be further structurally modified for new bioactive derivatives.
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